Literature DB >> 25444473

Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis.

John T Miura1, T Clark Gamblin2.   

Abstract

Management of liver malignancies, both primary and metastatic, requires a host of treatment modalities when attempting to prolong survival. Although surgical resection and transplantation continue to offer the best chance for a cure, most patients are not amenable to these therapies because of their advanced disease at presentation. Taking advantage of the unique blood supply of the liver, transarterial chemoembolization has emerged as an alternative and effective therapy for unresectable tumors. In this article, the current role along with future perspectives of transarterial chemoembolization for hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and colorectal liver metastasis are discussed.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Colorectal liver metastasis; Drug-eluting bead transarterial chemoembolization; Hepatocellular carcinoma; Intrahepatic cholangiocarcinoma; Liver; Locoregional therapies; Transarterial chemoembolization; Transarterial therapies

Mesh:

Substances:

Year:  2014        PMID: 25444473     DOI: 10.1016/j.soc.2014.09.004

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN: 1055-3207            Impact factor:   3.495


  5 in total

1.  Safety and efficacy of transarterial chemoembolization in patients with transjugular intrahepatic portosystemic shunts.

Authors:  John T Miura; William S Rilling; Sarah B White; Robert A Hieb; Sean M Tutton; Parag J Patel; T Clark Gamblin; Eric J Hohenwalter
Journal:  HPB (Oxford)       Date:  2015-08       Impact factor: 3.647

2.  Post-embolization syndrome as an early predictor of overall survival after transarterial chemoembolization for hepatocellular carcinoma.

Authors:  Meredith C Mason; Nader N Massarweh; Aitua Salami; Mark A Sultenfuss; Daniel A Anaya
Journal:  HPB (Oxford)       Date:  2015-09-16       Impact factor: 3.647

Review 3.  Clinical imaging of vascular disease in chronic kidney disease.

Authors:  Alan A Sag; Adrian Covic; Gerard London; Marc Vervloet; David Goldsmith; Jose Luis Gorriz; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2016-02-22       Impact factor: 2.370

Review 4.  Chemoembolization With Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma.

Authors:  Kathy Diener Dasse; Michael J Lander; Paula M Novelli
Journal:  J Adv Pract Oncol       Date:  2016-11-01

5.  Initial experience of drug-eluting bead transarterial chemoembolization with CalliSpheres® microspheres in treating liver metastases patients.

Authors:  Guangqiang Zhang; Rui Tang; Jianjun Wu; Kai Jin; Ming Chao; Bin Li
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.